Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
4.270
-0.330 (-7.17%)
At close: Aug 17, 2026, 4:00 PM EDT
4.255
-0.015 (-0.35%)
After-hours: Aug 17, 2026, 4:17 PM EDT
Clover Health Investments Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Clover Health Investments stock has a consensus rating of "Buy" and an average price target of $5.17. The average 1-year stock price forecast is 21.08% higher than the current stock price, while the lowest is $5.00 (+17.10%) and the highest is $5.50 (+28.81%).
Price Target: $5.17 (+21.08%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Clover Health Investments stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $5.5 | Buy | Maintains | $5.5 | +28.81% | Aug 12, 2026 |
| UBS | UBS | Hold Maintains $4.75 → $5 | Hold | Maintains | $4.75 → $5 | +17.10% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
2.95B
from 1.92B
Increased by 53.58%
Revenue Next Year
3.56B
from 2.95B
Increased by 20.65%
EPS This Year
0.14
from 0.04
Increased by 258.97%
EPS Next Year
0.15
from 0.14
Increased by 7.14%
EPS and Forward PE are based on non-GAAP adjusted numbers.